Abstract: The present invention provides a new pharmaceutical application of a 15,15-difluoroprostaglandin F2? derivative. As a result of intensive studies in order to find a new pharmaceutical application of a 15,15-difluoroprostaglandin F2? derivative, it was found that, in a European Phase III clinical trial for tafluprost, one of the 15,15-difluoroprostaglandin F2? derivatives, with patients with open-angle glaucoma or ocular hypertension, tafluprost has actions of growing eyelashes, making eyelashes thicker, and changing the color thereof, that is, has an effect of promoting the growth of hair (eyelashes). Therefore, a 15,15-difluoroprostaglandin F2? derivative is useful as a hair growth promoting agent, and is expected to be useful as an active ingredient of a preventive or therapeutic agent for a disease associated with hair such as alopecia and a hair care product or a hair cosmetic product for regrowing hair, growing hair, increasing hair density, nourishing hair, or the like.

Abstract: A process for polymerizing ethylene comprising contacting under polymerization condition ethylene and optionally one or more olefins with a catalyst system obtainable by contacting: a bis amido compound of formula (I) wherein Y is Si, Ge and Sn; X is hydrogen, halogen or an hydrocarbon radical; R1, R2, R3, R4, R5 and R6, are hydrocarbon radical; Q is a neutral Lewis base; and m is 0-2; one or more boron activating cocatalysts and one or more aluminum alkyls or alumoxanes.